中山大学孙逸仙纪念医院生殖中心,广东 广州 510120
潘孟茹,硕士生,研究方向:多囊卵巢综合征的基础与临床研究,E-mail:pmr17746079742@163.com
收稿:2022-03-24,
纸质出版:2022-07-20
移动端阅览
潘孟茹,李琳.肠促胰素在PCOS中的作用和机制[J].中山大学学报(医学科学版),2022,43(04):685-690.
PAN Meng-ru,LI Lin.The Role and Mechanism of Incretins in the Pathogenesis of PCOS[J].Journal of Sun Yat-sen University(Medical Sciences),2022,43(04):685-690.
潘孟茹,李琳.肠促胰素在PCOS中的作用和机制[J].中山大学学报(医学科学版),2022,43(04):685-690. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2022.0421.
PAN Meng-ru,LI Lin.The Role and Mechanism of Incretins in the Pathogenesis of PCOS[J].Journal of Sun Yat-sen University(Medical Sciences),2022,43(04):685-690. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2022.0421.
肠道菌群与疾病的关系为近年研究热点之一,肠-脑轴可能参与肥胖、糖尿病、多囊卵巢综合征(PCOS)等代谢相关疾病的发病机制。肠道菌群种类数量庞大,肠-脑轴的神经分泌调节机制尚不清楚,肠道菌群影响下丘脑-垂体-卵巢轴(HPO)的作用靶点难以准确定位。肠道内分泌激素近期受到关注,肠促胰素包括胰高血糖素样肽-1(GLP-1)和葡萄糖依赖性促胰岛素多肽(GIP)。这两种肠源性激素均可促进胰岛素的释放并降低血糖。目前国内外有关肠促胰素与HPO轴的研究较少,肠促胰素对PCOS的影响尚不明确。本文将综述该领域的研究进展,聚焦肠促胰素在PCOS发生发展中的可能作用与机制。
The relationship between gut microbiota and disease has become one of the hotspots in recent years. The gut-brain axis may be involved in the pathogenesis of metabolic diseases such as obesity, diabetes and polycystic ovary syndrome (PCOS), yet the mechanism of gut-brain axis in neuroencrine regulation is still unclear and the gut microbiota as a target to influence hypothalamic-pituitary-ovarian (HPO) axis remains uncertain. Recent reports indicate that enteroendocrine hormones may play a role. Incretins, including glucagon like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), could promote insulin release and reduce serum glucose level. While the research on incretins and HPO axis is still in its infancy, and the effects of incretins on PCOS has not yet been clarified. This review focuses on the possible role and mechanism of incretins in the pathogenesis of PCOS.
Jorsal T , Rhee NA , Pedersen J , et al . Enteroendocrine K and L cells in healthy and type 2 diabetic individuals [J]. Diabetologia , 2018 , 61 ( 2 ): 284 - 294 .
张莹莹 , 毛玉玲 , 张希 , 等 . PCOS患者血清中人组织激肽释放酶结合蛋白水平及其与肥胖的相关性分析 [J]. 新医学 , 2020 , 51 ( 9 ): 677 - 679 .
Zhang YY , Mao YL , Zhang X , et al . The level of human tissue kallikrein binding protein in serum of patients with PCOS and its correlation with obesity [J]. J New Med , 2020 , 51 ( 9 ): 677 - 679 .
Smith NK , Hackett TA , Galli A , et al . GLP-1: Molecular mechanisms and outcomes of a complex signaling system [J]. Neurochem Int , 2019 , 128 : 94 - 105 .
Müller TD , Finan B , Bloom SR , et al . Glucagon-like peptide 1 (GLP-1) [J]. Mol Metab , 2019 , 30 : 72 - 130 .
Hunt JE , Holst JJ , Jeppesen PB , et al . GLP-1 and intestinal diseases [J]. Biomedicines , 2021 , 9 ( 4 ): 383 .
Bagger JI , Grøndahl MFG , Lund A , et al . Glucagonostatic potency of GLP-1 in patients with type 2 diabetes, patients with type 1 diabetes, and healthy control subjects [J]. Diabetes , 2021 , 70 ( 6 ): 1347 - 1356 .
Conway G , Dewailly D , Diamanti-Kandarakis E , et al . The polycystic ovary syndrome: a position statement from the European Society of Endocrinology [J]. Eur J Endocrinol , 2014 , 171 ( 4 ): 1 - 29 .
Liu X , Zhang Y , Zheng SY , et al . Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight/obese polycystic ovary syndrome [J]. Clin Endocrinol (Oxf) , 2017 , 87 ( 6 ): 767 - 774 .
Nylander M , Frøssing S , HVClausen , et al . Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial [J]. Reprod Biomed Online , 2017 , 35 ( 1 ): 121 - 127 .
Lamos EM , Malek R , Davis SN . GLP-1 receptor agonists in the treatment of polycystic ovary syndrome [J]. Expert Rev Clin Pharmacol , 2017 , 10 ( 4 ): 401 - 408 .
Wu LM , Wang YX , Zhan Y , et al . Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats [J]. Peptides , 2021 , 145 : 170624 .
Gasbjerg LS , Christensen MB , Hartmann B , et al . GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study [J]. Diabetologia , 2018 , 61 ( 2 ): 413 - 423 .
Samms RJ , Sloop KW , Gribble FM , et al . GIPR function in the central nervous system: implications and novel perspectives for GIP-basedz therapies in treating metabolic disorders [J]. Diabetes , 2021 , 70 ( 9 ): 1938 - 1944 .
Stensen S , Gasbjerg LS , Krogh LL , et al . Effects of endogenous GIP in patients with type 2 diabetes . Eur J Endocrinol , 2021 , 185 ( 1 ): 33 - 45
Christensen MB , Lund A , Calanna S , et al . Glucose-dependent insulinotropic polypeptide (GIP) inhibits bone resorption independently of insulin and glycemia [J]. J Clin Endocrinol Metab , 2018 , 103 ( 1 ): 288 - 294 .
Boer GA , Holst JJ . Incretin hormones and type 2 diabetes-mechanistic insights and therapeutic approaches [J]. Biology (Basel) , 2020 , 9 ( 12 ): 473 .
Kanemaru Y , Harada N , Shimazu-Kuwahara S , et al . Absence of GIP secretion alleviates age-related obesity and insulin resistance [J]. J Endocrinol , 2020 , 245 ( 1 ): 13 - 20 .
Ahrén B , Yamada Y , Seino Y . The insulin response to oral glucose in GIP and GLP-1 receptor knockout mice: review of the literature and stepwise glucose dose response studies in female mice [J]. Front Endocrinol (Lausanne) , 2021 , 12 : 514 .
Killion EA , Wang J , Yie J , et al . Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models [J]. Sci Transl Med , 2018 , 10 ( 472 ): eaat3392 .
Camilleri M , Staiano A . Insights on obesity in children and adults: individualizing management [J]. Trends Endocrinol Metab , 2019 , 30 ( 10 ): 724 - 734 .
Pucci A , Batterham RL . Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different [J]. J Endocrinol Invest , 2019 , 42 ( 2 ): 117 - 128 .
Jamal M , Gunay Y , Capper A , et al . Roux-en-Y gastric bypass ameliorates polycystic ovary syndrome and dramatically improves conception rates: a 9-year analysis [J]. Surg Obes Relat Dis , 2012 , 8 ( 4 ): 440 - 444 .
Povysheva N , Zheng H , Rinaman L . Glucagon-like peptide 1 receptor-mediated stimulation of a GABAergic projection from the bed nucleus of the stria terminalis to the hypothalamic paraventricular nucleus [J]. Neurobiol Stress , 2021 , 15 : 100363 .
赵晏逵 , 李玉子 . GLP-1参与下丘脑室旁核小细胞神经元及心血管活动的研究进展 [J]. 中国老年学杂志 , 2020 , 40 ( 23 ): 5126 - 5130 .
Zhao YK , Li YZ . Research progress on the involvement of GLP-1 in small cell neurons in the paraventricular nucleus of hypothalamus and cardiovascular activity [J]. Chin J Gerontol , 2020 , 40 ( 23 ): 5126 - 5130 .
Beak SA , Heath MM , Small CJ , et al . Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line [J]. J Clin Invest , 1998 , 101 ( 6 ): 1334 - 1341 .
Zynat J , Guo Y , Lu Y , et al . The improvement of hyperglycemia after RYGB surgery in diabetic rats is related to elevated hypothalamus GLP-1 receptor expression [J]. Int J Endocrinol , 2016 , 2016 : 5308347 .
He Z , Gao Y , Lieu L , et al . Direct and indirect effects of liraglutide on hypothalamic POMC and NPY/AgRP neurons-Implications for energy balance and glucose control [J]. Mol Metab , 2019 , 28 : 120 - 134 .
Artunc-Ulkumen B , Pala HG , Pala EE , et al . Exenatide improves ovarian and endometrial injury and preserves ovarian reserve in streptozocin induced diabetic rats [J]. Gynecol Endocrinol , 2015 , 31 ( 3 ): 196 - 201 .
Dri M , Klinger FG , De Felici M . The ovarian reserve as target of insulin/IGF and ROS in metabolic disorder-dependent ovarian dysfunctions [J]. Reprod Fertil , 2021 , 2 ( 3 ): R103 - R112 .
Adriaenssens AE , Biggs EK , Darwish T , et al . Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake [J]. Cell Metab , 2019 , 30 ( 5 ): 987 - 996 .
Fu Y , Kaneko K , Lin HY , et al . Gut hormone GIP induces inflammation and insulin resistance in the hypothalamus [J]. Endocrinology , 2020 , 161 ( 9 ): bqaa102 .
Nishiyama Y , Hasegawa T , Fujita S , et al . Incretins modulate progesterone biosynthesis by regulating bone morphogenetic protein activity in rat granulosa cells [J]. J Steroid Biochem Mol Biol , 2018 , 178 : 82 - 88 .
Walters KA , Gilchrist RB , Ledger WL , et al . New perspectives on the pathogenesis of PCOS: neuroendocrine origins [J]. Trends Endocrinol Metab , 2018 , 29 ( 12 ): 841 - 852 .
Hoeger KM , Dokras A , Piltonen T . Update on PCOS: consequences, challenges, and guiding treatment [J]. J Clin Endocrinol Metab , 2021 , 106 ( 3 ): e1071 - e1083 .
Mantelli F , Moretti C , Macchi I , et al . Effects of sex hormones on ocular surface epithelia: lessons learned from polycystic ovary syndrome [J]. J Cell Physiol , 2016 , 231 ( 5 ): 971 - 975 .
Woo I , Tobler K , Khafagy A , et al . Predictive value of elevated LH/FSH ratio for ovulation induction in patients with polycystic ovary syndrome [J]. J Reprod Med , 2015 , 60 ( 11-12 ): 495 - 500 .
Vrbikova J , Hill M , Bendlova B , et al . Incretin levels in polycystic ovary syndrome [J]. Eur J Endocrinol , 2008 , 159 ( 2 ): 121 - 127 .
李萍 , 沙艳伟 , 丁露 , 等 . PCOS患者肠促胰素水平变化及其在发病中的作用研究 [J]. 中国妇幼保健 , 2015 , 30 ( 31 ): 5421 - 5423 .
Li P , Sha YW , Ding L , et al . Changes of incretin levels in patients with PCOS and its role in the pathogenesis [J]. Matern Child Health Care Chin , 2015 , 30 ( 31 ): 5421 - 5423 .
Svendsen PF , Nilas L , Madsbad S , et al . Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin [J]. Metabolism , 2009 , 58 ( 5 ): 586 - 593 .
Moffett RC , Naughton V . Emerging role of GIP and related gut hormones in fertility and PCOS [J]. Peptides , 2020 , 125 : 170233 .
0
浏览量
335
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
